Antiretroviral drug class exposure during 36 months of follow-up.

Distribution of participants exposed to each major ART class, including nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors, integrase strand transfer inhibitors, and CCR5 inhibitors. Exposure is categorized as remained on therapy throughout, discontinued, or never exposed during the 36-month follow-up period. Data are provided as a CSV file and archived in Figshare (DOI: 10.6084/m9.figshare.30032515).
(XLSX)

本数据集统计了暴露于各类主要抗逆转录病毒治疗（Antiretroviral Therapy, ART）类别的受试者分布情况，涵盖核苷/核苷酸类逆转录酶抑制剂（NRTIs）、非核苷类逆转录酶抑制剂（NNRTIs）、蛋白酶抑制剂、整合酶链转移抑制剂及CCR5抑制剂。在36个月的随访周期内，受试者的药物暴露情况被划分为三类：全程维持治疗、中断治疗以及从未暴露于该类药物。本数据集以逗号分隔值（CSV）文件形式提供，并存档于Figshare平台，其数字对象标识符（DOI）为10.6084/m9.figshare.30032515。（XLSX格式）